The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others.
In response to many inquiries from readers of Kalorama Information’s March 2003 publication Women’s Health: Worldwide Prescription Drug Markets, 3rd Edition, we embarked on a supplemental study that goes beyond the prescription market to cover over-the-counter products in the United States.
The report covers the following segments:
- Adult incontinence
- Menstrual pain relievers
- Family planning
- Feminine hygiene, and
Amongst these segments, new product development and additional regulatory review and approval of new OTC drug classifications in areas including infection, family planning and osteoporosis are likely to have the greatest impact on this market.
The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, current OTC products on the market, market estimates and forecasts, and competitive analysis of leading players. In addition to abovementioned information, the report includes current trends and opportunities affecting the industry and present and future market drivers.
The information for this report was gathered using secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.
All market data pertain to the U.S. market. The base year for data was 2002. Historical data are provided for 1998 through 2002, with forecast data provided for 2003 through 2006. Compound annual growth rates (CAGRs) are provided for the 1998-2002, 2003-2006, and 1998-2006 periods for each industry segment covered.